13F-HR filed by Boxer Capital, LLC
Boxer Capital, LLC filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-14, with 27 holding rows worth $420,500,000.
- Accession
- 0000950123-17-008000
- Filer
- CIK 1465837
- Filed
- 2017-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2017
A holdings report, 27 entries on the cover page, a total value of $420,500,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $420,502,000 with VALUE read as thousands by filing date, 13F file number 028-17339. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerAviva Holdings Ltd. 028-17342
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AVEXIS INC | 05366U100 | COM | 800,000 | $65,728,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 500,000 | $46,815,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 1,000,000 | $46,280,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 1,215,000 | $46,182,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 2,115,000 | $37,034,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 1,700,000 | $31,161,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 600,000 | $27,000,000 | thousands by filing date | |
| MEDICINES COMPANY | 584688905 | COM | 530,600 | $20,168,000 | thousands by filing date | call |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 250,000 | $12,668,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 100,000 | $12,591,000 | thousands by filing date | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 629,179 | $10,973,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 100,000 | $8,740,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 267,500 | $7,963,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 525,000 | $7,387,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 940,000 | $6,721,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 125,000 | $6,468,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 533,251 | $4,959,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,037,994 | $3,789,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 234,220 | $3,272,000 | thousands by filing date | |
| BARCLAYS BK PLC | 06740Q252 | IPATH S&P500 VIX | 250,000 | $3,190,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328700 | COM | 1,025,000 | $2,768,000 | thousands by filing date | |
| BELLEROPHON THERAPEUTICS INC | 078771102 | COM | 1,857,143 | $2,489,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 425,000 | $2,448,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS AG | 62957M104 | SPONSORED ADR | 176,710 | $1,852,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 138,331 | $1,093,000 | thousands by filing date | |
| ONCONOVA THERAPEUTICS INC COM PAR | 68232V306 | Stock | 302,886 | $654,000 | thousands by filing date | |
| ONCONOVA THERAPEUTICS INC | 68232V116 | *W EXP 07/11/202 | 241,644 | $109,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-17-008000 | this filing | 2017-08-14 | acceptance time not in the bulk data set |